Lost in translation: a disconnect between the science and Medicare coverage criteria for continuous subcutaneous insulin infusion Journal Article uri icon
  • Numerous studies have demonstrated the clinical value and safety of insulin pump therapy in type 1 diabetes and type 2 diabetes populations. However, the eligibility criteria for insulin pump coverage required by the Centers for Medicare & Medicaid Services (CMS) discount conclusive evidence that supports insulin pump use in diabetes populations that are currently deemed ineligible. This article discusses the limitations and inconsistencies of the insulin pump eligibility criteria relative to current scientific evidence and proposes workable solutions to address this issue and improve the safety and care of all individuals with diabetes.

  • Link to Article
    publication date
  • 2021
  • published in
  • Diabetes
  • Drugs and Drug Therapy
  • Medicare
  • Safety
  • Additional Document Info
  • 23
  • issue
  • 10